Cutter G - Search Results

1

Reproducibility of optical coherence tomography in multiple sclerosis.

Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, Zhang X, Cutter G, Balcer LJ, Frohman EM, Calabresi PA. Cettomai D, et al. Among authors: cutter g. Arch Neurol. 2008 Sep;65(9):1218-22. doi: 10.1001/archneur.65.9.1218. Arch Neurol. 2008. PMID: 18779426

2

New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis.

Balcer LJ, Baier ML, Pelak VS, Fox RJ, Shuwairi S, Galetta SL, Cutter GR, Maguire MG. Balcer LJ, et al. Among authors: cutter gr. Mult Scler. 2000 Jun;6(3):163-71. doi: 10.1177/135245850000600305. Mult Scler. 2000. PMID: 10871827 Clinical Trial.

3

Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life.

Miller DM, Rudick RA, Cutter G, Baier M, Fischer JS. Miller DM, et al. Among authors: cutter g. Arch Neurol. 2000 Sep;57(9):1319-24. doi: 10.1001/archneur.57.9.1319. Arch Neurol. 2000. PMID: 10987899

4

Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25).

Balcer LJ, Baier ML, Kunkle AM, Rudick RA, Weinstock-Guttman B, Simonian N, Galetta SL, Cutter GR, Maguire MG. Balcer LJ, et al. Among authors: cutter gr. Mult Scler. 2000 Dec;6(6):382-5. doi: 10.1177/135245850000600604. Mult Scler. 2000. PMID: 11212133

5

Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.

Rudick RA, Cutter G, Baier M, Fisher E, Dougherty D, Weinstock-Guttman B, Mass MK, Miller D, Simonian NA. Rudick RA, et al. Among authors: cutter g. Neurology. 2001 May 22;56(10):1324-30. doi: 10.1212/wnl.56.10.1324. Neurology. 2001. PMID: 11376182

6

Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.

Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Jak AJ, Kniker JE, Kooijmans MF, Lull JM, Sandrock AW, Simon JH, Simonian NA, Whitaker JN. Cohen JA, et al. Among authors: cutter gr. Arch Neurol. 2001 Jun;58(6):961-7. doi: 10.1001/archneur.58.6.961. Arch Neurol. 2001. PMID: 11405811 Clinical Trial.

7

Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite.

Balcer LJ, Baier ML, Cohen JA, Kooijmans MF, Sandrock AW, Nano-Schiavi ML, Pfohl DC, Mills M, Bowen J, Ford C, Heidenreich FR, Jacobs DA, Markowitz CE, Stuart WH, Ying GS, Galetta SL, Maguire MG, Cutter GR. Balcer LJ, et al. Among authors: cutter gr. Neurology. 2003 Nov 25;61(10):1367-73. doi: 10.1212/01.wnl.0000094315.19931.90. Neurology. 2003. PMID: 14638957

8

Effect of relapses on development of residual deficit in multiple sclerosis.

Lublin FD, Baier M, Cutter G. Lublin FD, et al. Among authors: cutter g. Neurology. 2003 Dec 9;61(11):1528-32. doi: 10.1212/01.wnl.0000096175.39831.21. Neurology. 2003. PMID: 14663037

9

Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.

Baier ML, Cutter GR, Rudick RA, Miller D, Cohen JA, Weinstock-Guttman B, Mass M, Balcer LJ. Baier ML, et al. Among authors: cutter gr. Neurology. 2005 Mar 22;64(6):992-5. doi: 10.1212/01.WNL.0000154521.40686.63. Neurology. 2005. PMID: 15781814 Clinical Trial.

10

MRI as a marker for disease heterogeneity in multiple sclerosis.

Bielekova B, Kadom N, Fisher E, Jeffries N, Ohayon J, Richert N, Howard T, Bash CN, Frank JA, Stone L, Martin R, Cutter G, McFarland HF. Bielekova B, et al. Among authors: cutter g. Neurology. 2005 Oct 11;65(7):1071-6. doi: 10.1212/01.wnl.0000178984.30534.f9. Neurology. 2005. PMID: 16217061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

844 results

Search Page

Filters